This site is intended for healthcare professionals
News

Sobi and Apellis collaborate on the development and commercialisation of pegcetacoplan.

Read time: 2 mins
Last updated:29th Oct 2020
Published:28th Oct 2020
Condition: Paroxysmal Nocturnal Haemoglobinuria
Type: drug
Register free for full access to medthority.com